Related Experiment Videos
c-kit gene mutations in intracranial germinomas.
Yuji Sakuma1, Shinji Sakurai, Sachiko Oguni
1Department of Pathology, Jichi Medical School, Minamikawachi-machi, Kawachi-gun, Tochigi 329-0498, Japan.
Cancer Science
|October 9, 2004
Summary
Intracranial germinomas, rare brain tumors, harbor c-kit gene mutations in 25% of cases, similar to gonadal germ cell tumors. These findings suggest potential therapeutic strategies targeting KIT mutations.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gain-of-function mutations in the c-kit gene are prevalent in gastrointestinal stromal tumors and mastocytosis.
- KIT mutations are identified in a subset of gonadal germinomas, but their presence in intracranial germinomas is unknown.
Purpose of the Study:
- To investigate the occurrence, frequency, and specific locations of c-kit gene mutations within intracranial germinomas.
Main Methods:
- Analysis of five c-kit gene mutational hotspots (exons 9, 10, 11, 13, and 17) in genomic DNA from 16 intracranial germinomas.
- Utilized polymerase chain reaction and direct sequencing techniques.
Main Results:
- c-kit gene mutations were detected in four (25.0%) intracranial germinomas, specifically at exon 11 (W557C) or exon 17 (D816V, D820V, N822Y).
- No significant correlation was observed between c-kit mutations and clinicopathological factors.
- The mutation profile in intracranial germinomas mirrors that of gonadal germinomas.
Conclusions:
- Intracranial germinomas share molecular similarities with gonadal germinomas, supporting their classification as counterparts.
- The presence of c-kit mutations suggests that molecularly targeted therapies, such as imatinib mesylate, may offer a promising treatment avenue for intracranial germinomas harboring these mutations.